1-2 of 2
Michael Peel, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ruxolitinib, a JAK1/2 Inhibitor, Is Efficacious in a Novel Humanized GvHD Model Characterized By Enhanced NK, NK-T and T-Cell Engraftment

Eduardo Huarte, PhD, Michael Peel, PhD, Philip Dube, PhD, Lynn Stephens, Becky Stewart, Brian Long, Philip Czerniak, Julian Oliver, PhD, Paul Smith, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 21–22.
https://doi.org/10.1182/blood-2020-139805
Published: 2020
Journal Articles

Translationally Relevant Oral Ruxolitinib Dosing Reduces Inflammation and Ameliorates Disease in Murine Models of Hemophagocytic Lymphohistiocytosis

Eduardo Huarte, PhD, Michael Peel, PhD, Katherine Verbist, PhD, Brittany Fay, Sabrin Albeituni, PhD, Kim E. Nichols, MD, Paul Smith, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 21.
https://doi.org/10.1182/blood-2020-139539
Published: 2020